1、The atorvastatin group found no serious adverse reactions.
阿托伐他汀組未發(fā)現嚴重的不良反應。

2、Carotid artery atherosclerosis; Atorvastatin calcium; Conventional treatment.
頸動脈粥樣硬化；阿托伐他汀鈣；常規(guī)治療。

3、CONCLUSION: Atorvastatin can increase ABCA1 mediated intracellular cholesterol efflux.
結論：阿托伐他汀促進ABCA1介導的細胞內膽固醇外流。

4、Conclusions: Atorvastatin may improve heart function of patients with DCM heart failure.
結論：托伐他汀可進一步改善DC M心力衰竭患者的心功能。

5、Objective to study the influence of atorvastatin on the atherosclerosis plaque of carotid artery.
目的研究阿托伐他汀對頸動脈粥樣硬化斑塊的影響。

6、Conclusion Atorvastatin is similar in curative effect and safety to Xuezhikang.
結論血脂康與阿托伐他汀降脂療效與安全性相似。